{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:52:29Z","timestamp":1781844749494,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To describe the longitudinal changes in retinal neovascularization elsewhere (NVE) as observed on optical coherence tomography angiography (OCTA) in proliferative diabetic retinopathy (PDR) treated by panretinal photocoagulation (PRP).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Each patient included in this prospective clinical study was newly diagnosed with PDR and NVE confirmed by both fundus fluorescein angiography (FFA) and OCTA. They received four sessions of PRP using a multiwavelength laser. Best-corrected visual acuity (BCVA) and OCTA images of the NVE were obtained before each PRP session and at 1\u2009month, 3\u2009months, and 6\u2009months after the PRP treatment. Generalized estimating equations (GEE) was used to investigate the differences between the BCVA and NVE areas before and after PRP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty-two eyes of 32 patients with a mean age of 50.56\u2009\u00b1\u20097.05\u2009years were included. We found a statistically significant reduction in the NVE area at all time points compared with the baseline except at 6\u2009months (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Further analysis demonstrated no statistically significant change in the NVE area between two adjacent timepoints except from baseline to post-1st PRP (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). BCVA at 3\u2009months showed a statistically significant improvement compared with baseline (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), but no significant changes in BCVA were observed during the other visits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We found an overall regression in the NVE area following PRP starting as early as 1\u2009week after the 1st session and lasting up to 3\u2009months. OCTA provides quantitative information on vascular changes and could be a practical method for the longitudinal evaluation of neovascularization.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-021-01964-w","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T11:03:51Z","timestamp":1623063831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Observation of retinal neovascularization using optical coherence tomography angiography after panretinal photocoagulation for proliferative diabetic retinopathy"],"prefix":"10.1186","volume":"21","author":[{"given":"H. E.","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. U.","family":"Weihong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangtian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"issue":"9","key":"1964_CR1","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2013.168118","volume":"310","author":"Y Xu","year":"2013","unstructured":"Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948\u201359.","journal-title":"JAMA"},{"issue":"13","key":"1964_CR2","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227\u201339.","journal-title":"N Engl J Med"},{"key":"1964_CR3","first-page":"969","volume-title":"Proliferative Diabetic Retinopathy.In: Stephen J. Ryan editor-in-chief. Retina","author":"P Silva","year":"2013","unstructured":"Silva P, Cavallerano JD, Sun JK, et al. Proliferative Diabetic Retinopathy.In: Stephen J. Ryan editor-in-chief. Retina. 5th ed. Philadelphia: Elsevier; 2013. p. 969\u20131000.","edition":"5"},{"issue":"5","key":"1964_CR4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0161-6420(13)38011-7","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1991","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology. 1991;98(5):766\u201385.","journal-title":"Ophthalmology"},{"issue":"11","key":"1964_CR5","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1097\/IAE.0000000000000716","volume":"35","author":"TS Hwang","year":"2015","unstructured":"Hwang TS, Jia Y, Gao SS, Bailey ST, Lauer AK, Flaxel CJ, et al. Optical coherence tomography angiography features of diabetic retinopathy. Retina. 2015;35(11):2371\u20136.","journal-title":"Retina"},{"issue":"14","key":"1964_CR6","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1167\/iovs.16-20210","volume":"57","author":"A Ishibazawa","year":"2016","unstructured":"Ishibazawa A, Nagaoka T, Yokota H, Takahashi A, Omae T, Song YS, et al. Characteristics of retinal neovascularization in proliferative diabetic retinopathy imaged by optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57(14):6247\u201355.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1964_CR7","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1167\/iovs.17-21551","volume":"58","author":"DM Sampson","year":"2017","unstructured":"Sampson DM, Gong P, An D, Menghini M, Hansen A, Mackey DA, et al. Axial length variation impacts on superficial retinal vessel density and Foveal avascular zone area measurements using optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2017;58(7):3065\u201372.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1964_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF00175988","volume":"232","author":"AG Bennett","year":"1994","unstructured":"Bennett AG, Rudnicka AR, Edgar DF. Improvements on Littmann's method of determining the size of retinal features by fundus photography. Graefes Arch Clin Exp Ophthalmol. 1994;232(6):361\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1964_CR9","unstructured":"American Academy of Ophthalmology Retina\/Vitreous Panel. Preferred practice pattern guidelines: diabetic retinopathy: American Academy of Ophthalmology; 2019."},{"issue":"2","key":"1964_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0161-6420(88)33212-4","volume":"95","author":"GW Blankenship","year":"1988","unstructured":"Blankenship GW. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology. 1988;95(2):170\u20137.","journal-title":"Ophthalmology"},{"issue":"11","key":"1964_CR11","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S0161-6420(93)31421-1","volume":"100","author":"The Krypton Argon Regression Neovascularization Study","year":"1993","unstructured":"The Krypton Argon Regression Neovascularization Study. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The krypton argon regression neovascularization study report number 1. Ophthalmology. 1993;100(11):1655\u201364.","journal-title":"Ophthalmology"},{"issue":"10","key":"1964_CR12","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0161-6420(91)32085-2","volume":"98","author":"JF Vander","year":"1991","unstructured":"Vander JF, Duker JS, Benson WE, Brown GC, Mcnamara JA, Rosenstein RB. Long-term stability and visual outcome after favorable initial response of proliferative diabetic-retinopathy to Panretinal photocoagulation. Ophthalmology. 1991;98(10):1575\u20139.","journal-title":"Ophthalmology"},{"issue":"4","key":"1964_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.oret.2018.11.008","volume":"3","author":"JF Russell","year":"2019","unstructured":"Russell JF, Shi Y, Hinkle JW, Scott NL, Fan KC, Lyu C, et al. Longitudinal wide-field swept-source OCT angiography of neovascularization in proliferative diabetic retinopathy after Panretinal photocoagulation. Ophthalmol Retina. 2019;3(4):350\u201361.","journal-title":"Ophthalmol Retina"},{"key":"1964_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ajo.2019.04.032","volume":"206","author":"AA Fawzi","year":"2019","unstructured":"Fawzi AA, Fayed AE, Linsenmeier RA, Gao J, Yu F. Improved macular capillary flow on optical coherence tomography angiography after Panretinal photocoagulation for proliferative diabetic retinopathy. Am J Ophthalmol. 2019;206:217.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1964_CR15","doi-asserted-by":"publisher","first-page":"e0214892","DOI":"10.1371\/journal.pone.0214892","volume":"14","author":"M Pellegrini","year":"2019","unstructured":"Pellegrini M, Cozzi M, Staurenghi G, Corvi F. Comparison of wide field optical coherence tomography angiography with extended field imaging and fluorescein angiography in retinal vascular disorders. PLoS One. 2019;14(4):e0214892.","journal-title":"PLoS One"},{"issue":"9","key":"1964_CR16","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1136\/bjophthalmol-2017-311358","volume":"102","author":"T Hirano","year":"2018","unstructured":"Hirano T, Kakihara S, Toriyama Y, Nittala MG, Murata T, Sadda S. Wide-field en face swept-source optical coherence tomography angiography using extended field imaging in diabetic retinopathy. Br J Ophthalmol. 2018;102(9):1199\u2013203.","journal-title":"Br J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-01964-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-01964-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-01964-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T11:05:48Z","timestamp":1623063948000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-01964-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1964"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-01964-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]},"assertion":[{"value":"14 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Peking Union Medical College Hospital. All procedures were carried in accordance with the tenets of the Declaration of Helsinki. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"252"}}